WO2007141346A3 - Genes regulating intracellular cholesterol trafficking as targets for treatment of cholesterol-related diseases - Google Patents
Genes regulating intracellular cholesterol trafficking as targets for treatment of cholesterol-related diseases Download PDFInfo
- Publication number
- WO2007141346A3 WO2007141346A3 PCT/EP2007/055726 EP2007055726W WO2007141346A3 WO 2007141346 A3 WO2007141346 A3 WO 2007141346A3 EP 2007055726 W EP2007055726 W EP 2007055726W WO 2007141346 A3 WO2007141346 A3 WO 2007141346A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cholesterol
- related diseases
- targets
- treatment
- trafficking
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to novel genes, which regulate the intracellular cholesterol trafficking and which are involved in the development and/or progression of cholesterol- related diseases, disorders or conditions, such as neurological diseases, for example neurodegenerative conditions, e. g. Niemann-Pick type C disease. The invention also relates to the use of the said genes as novel drug targets for the development of medicaments useful to treat, prevent or ameliorate the said cholesterol-related diseases, disorders or conditions.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07730060A EP2032599A2 (en) | 2006-06-09 | 2007-06-11 | Genes regulating intracellular cholesterol trafficking as targets for treatment of cholesterol-related diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0611463.1 | 2006-06-09 | ||
GB0611463A GB0611463D0 (en) | 2006-06-09 | 2006-06-09 | Organic compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2007141346A2 WO2007141346A2 (en) | 2007-12-13 |
WO2007141346A3 true WO2007141346A3 (en) | 2008-04-03 |
WO2007141346A9 WO2007141346A9 (en) | 2009-10-01 |
Family
ID=36745624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/055726 WO2007141346A2 (en) | 2006-06-09 | 2007-06-11 | Genes regulating intracellular cholesterol trafficking as targets for treatment of cholesterol-related diseases |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2032599A2 (en) |
GB (1) | GB0611463D0 (en) |
WO (1) | WO2007141346A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2680222T3 (en) | 2008-05-22 | 2018-09-05 | H. Lundbeck A/S | Modulation of the Vps10p domain receptors for the treatment of cardiovascular disease |
CN102647995B (en) | 2009-06-10 | 2015-07-08 | 奥胡斯大学 | SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto |
NZ605871A (en) * | 2010-06-25 | 2015-02-27 | Shire Human Genetic Therapies | Treatment of sanfilippo syndrome type b |
EP3964229A1 (en) | 2010-06-25 | 2022-03-09 | Shire Human Genetic Therapies, Inc. | Methods and compositions for cns delivery of iduronate-2-sulfatase |
CA3171308A1 (en) | 2010-06-25 | 2011-12-29 | Shire Human Genetic Therapies, Inc. | Methods and compositions for cns delivery of iduronate-2-sulfatase |
ES2650689T3 (en) | 2010-06-25 | 2018-01-19 | Shire Human Genetic Therapies, Inc. | Administration of therapeutic agents to the central nervous system |
JP6073783B2 (en) | 2010-06-25 | 2017-02-01 | シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド | Methods and compositions for CNS delivery of heparan N-sulfatase |
CN103282046B (en) | 2010-06-25 | 2015-05-13 | 夏尔人类遗传性治疗公司 | Methods and compositions for CNS delivery of arylsulfatase A |
BR112013022557A2 (en) * | 2011-03-04 | 2017-08-01 | Shire Human Genetic Therapies | peptide binders polypeptide compositions and methods for using them |
US8580922B2 (en) | 2011-03-04 | 2013-11-12 | Shire Human Genetic Therapies, Inc. | Peptide linkers for polypeptide compositions and methods for using same |
WO2013096899A2 (en) | 2011-12-23 | 2013-06-27 | Shire Human Genetic Therapies, Inc. | Stable formulations for cns delivery of arylsulfatase a |
-
2006
- 2006-06-09 GB GB0611463A patent/GB0611463D0/en not_active Ceased
-
2007
- 2007-06-11 EP EP07730060A patent/EP2032599A2/en not_active Withdrawn
- 2007-06-11 WO PCT/EP2007/055726 patent/WO2007141346A2/en active Application Filing
Non-Patent Citations (3)
Title |
---|
GOLDSTEIN JOSEPH L ET AL: "Protein sensors for membrane sterols", CELL, vol. 124, no. 1, January 2006 (2006-01-01), pages 35 - 46, XP002458950, ISSN: 0092-8674 * |
HUA X ET AL: "STEROL RESISTANCE IN CHO CELLS TRACED TO POINT MUTATION IN SREBP CLEAVAGE-ACTIVATION PROTEIN", CELL, CELL PRESS, CAMBRIDGE, NA, US, vol. 87, 1 November 1996 (1996-11-01), pages 415 - 426, XP002943470, ISSN: 0092-8674 * |
RAMJAUN ANTOINE R ET AL: "Identification and characterization of a nerve terminal-enriched amphiphysin isoform", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 26, 1997, pages 16700 - 16706, XP002458951, ISSN: 0021-9258 * |
Also Published As
Publication number | Publication date |
---|---|
GB0611463D0 (en) | 2006-07-19 |
EP2032599A2 (en) | 2009-03-11 |
WO2007141346A2 (en) | 2007-12-13 |
WO2007141346A9 (en) | 2009-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007141346A3 (en) | Genes regulating intracellular cholesterol trafficking as targets for treatment of cholesterol-related diseases | |
WO2007022470A3 (en) | Methods and compositions for treating neurological disease | |
WO2006058868A8 (en) | Substituted pteridines for treating inflammatory diseases | |
WO2008074329A3 (en) | Modulation of activity of proneurotrophins | |
WO2007133812A3 (en) | Improved carriers for delivery of nucleic acid agents to cells and tissues | |
WO2006058867A3 (en) | Substituted pteridines for the treatment of inflammatory diseases | |
WO2007002516A3 (en) | Improved dosage forms for movement disorder treatment | |
WO2005116088A3 (en) | Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells | |
WO2010048332A3 (en) | Compounds for treating ophthalmic diseases and disorders | |
WO2006058869A3 (en) | Substituted pteridines for treating inflammatory diseases | |
WO2010057112A3 (en) | Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets | |
WO2008002621A3 (en) | Benzyl-substituted quinolone m1 receptor positive allosteric modulators | |
EP2305640A3 (en) | Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases | |
WO2005116212A3 (en) | Treatment of neurodegenerative disease through intracranial delivery of sirna | |
WO2017070647A8 (en) | Nicotinamide for use in the treatment and prevention of ocular neurodegenerative disorder (e.g. glaucoma) | |
WO2007141796A3 (en) | Therapeutic uses of inhibitors of rtp801l | |
WO2008054544A3 (en) | Method for delivery across the blood brain barrier | |
WO2006055625A3 (en) | Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors | |
WO2008080082A3 (en) | Methods for modulating set and uses thereof | |
EP2402443A3 (en) | Therapeutic uses of inhibitors of rtp801 | |
WO2008087186A3 (en) | Peptides for use in the treatment of obesity | |
WO2010080452A3 (en) | siRNA COMPOUNDS AND METHODS OF USE THEREOF | |
WO2008008359A3 (en) | Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor | |
WO2008097924A3 (en) | Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders | |
WO2009005794A3 (en) | Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07730060 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007730060 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |